Obesity, DM, and NAFLD are chronic metabolic diseases; therefore, we hypothesized that ERS is associated with the occurrence and development of T2DM with NAFLD as a comorbidity by inhibiting autophagy and that the ER-autophagy receptor FAM134B plays an important role in this process. The gene discussed is RETREG1; the disease is type 2 diabetes mellitus.